![Close up of a hand using a tablet](/wp-content/themes/yootheme/cache/63/iStock-918656496-1600x575-1-63f288bf.jpeg)
![Close up of a hand using a tablet](/wp-content/themes/yootheme/cache/63/iStock-918656496-1600x575-1-63f288bf.jpeg)
Latest News
IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies
February 9, 2024
Following the elections held for the position of Chair of the International Osteoporosis Foundation (IOF) Committee of National Societies (CNS), Dr. Famida Jiwa, President and CEO, Osteoporosis Canada has been elected Chair for the term 2024-2028.
As Chair of the IOF CNS, Dr. Jiwa will be sitting on the Board of Trustees as an ex-officio member and her term as Chair of the CNS will formally start in April 2024, on the occasion of the Committee of National Societies Annual Meeting, planned in London on April 11, 2024.
Dr. Jiwa will have the opportunity to designate the Vice-Chair of the CNS, who will be introduced to all CNS Members during the CNS Annual Meeting in London.
Congratulations to Dr. Famida Jiwa.
![IOF Logo](/wp-content/themes/yootheme/cache/43/WEB-IOF-Logo-600px-Blue-WEB-43d41348.png)
OC MAKES THE NEWS – RECENT ITEMS
Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis.
May 31, 2024
Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]
Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement
April 19, 2024
Latest News Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement April 19, 2024 The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, […]
Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture
April 3, 2024
Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]